Genetics Generation Advancement Corp. (4160.TWO)
TWD 70.2
(-2.9%)
TWD 70.2
(-2.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 66.85 Million | 51.8 Million | 7.32 Million | 26.69 Million | - |
| Net Income | 34.74 Million | 33.19 Million | 10.19 Million | -18.27 Million | - |
| Depreciation & Amortization | 15.44 Million | 10.7 Million | 10.22 Million | 7.35 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 954 Thousand | - | - | - | - |
| Change in working capital | 17.69 Million | 4.88 Million | -13.1 Million | 35.18 Million | - |
| Other non-cash items | -2.02 Million | -569 Thousand | -168 Thousand | -947 Thousand | - |
| Investing Cash Flow | -7.8 Million | -71.52 Million | 10.18 Million | 14.14 Million | - |
| Investments in PPE | -5.11 Million | -8.14 Million | -10.43 Million | -20.4 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -100.21 Million | -154.96 Million | -24.59 Million | - | - |
| Sales/Maturities of investments | 97.73 Million | 91.1 Million | 46.37 Million | 34.95 Million | - |
| Other Investing Activities | -200 Thousand | 475 Thousand | -1.16 Million | -416 Thousand | - |
| Financing Cash Flow | 12.24 Million | -7.79 Million | -751 Thousand | -16.39 Million | - |
| Debt repayment | -30 Million | - | - | - | - |
| Dividends payments | -11.57 Million | -7.05 Million | - | -16.47 Million | -15.19 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -6.17 Million | - | -250 Thousand | 250 Thousand | - |
| Accounts receivables | -164 Thousand | - | - | - | - |
| Accounts payables | 2.4 Million | - | - | - | - |
| Inventory | -3.5 Million | 28.41 Million | -4.37 Million | 19.77 Million | - |
| Other working capital | 21.36 Million | - | - | - | - |
| Cash at beginning of period | 57.44 Million | 85.27 Million | 68.7 Million | 44.58 Million | - |
| Cash at end of period | 128.48 Million | 57.44 Million | 85.27 Million | 68.7 Million | - |
| Capital Expenditure | -5.11 Million | -8.14 Million | -10.43 Million | -20.4 Million | - |
| Effect of forex changes on cash | -267 Thousand | -320 Thousand | -182 Thousand | -317 Thousand | - |
| Net cash flow / Change in cash | 71.03 Million | -27.83 Million | 16.57 Million | 24.12 Million | - |
| Free Cash Flow | 61.74 Million | 43.66 Million | -3.1 Million | 6.29 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.11 Million | 17.89 Million | 34.74 Million | 8.58 Million | 5.94 Million | 10.99 Million |
| Depreciation & Amortization | 4.52 Million | 4.01 Million | 15.44 Million | 4.09 Million | 4.24 Million | 4.43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 309 Thousand | 308 Thousand | 954 Thousand | 199 Thousand | 755 Thousand | - |
| Change in working capital | -17.72 Million | -7.88 Million | 17.69 Million | 30.91 Million | -13.53 Million | -8.23 Million |
| Other non-cash items | -650 Thousand | -659 Thousand | -2.02 Million | -335 Thousand | -273 Thousand | -534 Thousand |
| Investing Cash Flow | -68.89 Million | 19.42 Million | -7.8 Million | -3.37 Million | -18.86 Million | 50.67 Million |
| Investments in PPE | -17.05 Million | -281 Thousand | -5.11 Million | -2.38 Million | -519 Thousand | -1.69 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -52.16 Million | -285 Thousand | -100.21 Million | -227 Thousand | -59.77 Million | 10.7 Million |
| Sales/Maturities of investments | 800 Thousand | 20.05 Million | 97.73 Million | 225 Thousand | 41.56 Million | 40.8 Million |
| Other Investing Activities | -468 Thousand | -60 Thousand | -200 Thousand | -988 Thousand | -137 Thousand | 856 Thousand |
| Financing Cash Flow | 27.97 Million | -32.01 Million | 12.24 Million | 16.41 Million | -1.99 Million | -11.98 Million |
| Debt repayment | -30 Million | -30 Million | -30 Million | - | - | -10 Million |
| Dividends payments | - | - | -11.57 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 30 Million | - | - | - | - | - |
| Accounts receivables | -14.3 Million | - | - | - | - | - |
| Accounts payables | -7.53 Million | - | - | - | - | - |
| Inventory | -1 Million | 43 Thousand | -3.5 Million | -4.21 Million | 3.21 Million | -848 Thousand |
| Other working capital | 3.12 Million | - | - | - | - | - |
| Cash at beginning of period | 129.98 Million | 128.48 Million | 57.44 Million | 71.98 Million | 94.76 Million | 49.45 Million |
| Cash at end of period | 95.56 Million | 129.98 Million | 128.48 Million | 128.48 Million | 71.98 Million | 94.76 Million |
| Capital Expenditure | -17.05 Million | -281 Thousand | -5.11 Million | -2.38 Million | -519 Thousand | -1.69 Million |
| Effect of forex changes on cash | 74 Thousand | 62 Thousand | -267 Thousand | -136 Thousand | 182 Thousand | -230 Thousand |
| Net cash flow / Change in cash | -34.42 Million | 1.5 Million | 71.03 Million | 56.49 Million | -22.77 Million | 45.31 Million |
| Free Cash Flow | -10.63 Million | 13.74 Million | 61.74 Million | 41.2 Million | -2.62 Million | 5.16 Million |
SXTP
REDINGTON
1619
K
VGUARD
3209